Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions

International Endodontic Journal

Volumn 43, Issue 6, 2010, Pages 485-491

  Xiong, H ^a   Wei, L ^a   Hu, Y ^a   Zhang, C ^a   Peng, Bin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Alendronate; Angiogenesis; Bone resorption; Periapical lesions

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE;

ALVEOLAR BONE LOSS; ANGIOGENESIS; ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; JAW; MALE; MANDIBLE; METABOLISM; MICROVASCULATURE; NONPARAMETRIC TEST; OSTEOLYSIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TOOTH PERIAPICAL DISEASE; COMPLICATION; DRUG EFFECTS;

ACID PHOSPHATASE; ALENDRONATE; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ISOENZYMES; MALE; MANDIBLE; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIAPICAL DISEASES; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC;

EID: 77953731951     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/j.1365-2591.2010.01703.x     Document Type: Article

References (35)

1. Anan H, Akamine A, Maeda K. An enzyme histochemical study of the behavior of rat bone cells during experimental apical periodontitis. Journal of Endodontics 1993, 19:83-6.
2. Badros A, Weikel D, Salama A. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. Journal of Clinical Oncology 2006, 24:945-52.
3. Balto K, Müller R, Carrington DC, Dobeck J, Stashenko P. Quantification of periapical bone destruction in mice by micro-computed tomography. Journal of Dental Research 2000, 79:35-40.
4. Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 2001, 28:465-73.
5. Cetinkaya BO, Keles GC, Ayas B, Gurgor P. Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats. Journal of Periodontology 2008, 79:1950-61.
6. Chapurlat RD, Delmas PD. Drug insight: bisphosphonates for postmenopausal osteoporosis. Nature clinical practice. Endocrinology & metabolism 2006, 2:211-9.
7. Corotti MV, Zambuzzi WF, Paiva KB. Immunolocalization of matrix metalloproteinases-2 and -9 during apical periodontitis development. Archives of Oral Biology 2009, 54:764-71.
8. Duarte PM, de Assis DR, Casati MZ, Sallum AW, Sallum EA, Nociti FH. Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats. Journal of Periodontology 2004, 75:1196-202.
9. Gao Y, Zou S, Liu X, Bao C, Hu J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 2009, 30:1790-6.
10. Hikita H, Miyazawa K, Tabuchi M, Kimura M, Goto S. Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats. Journal of Bone and Mineral Metabolism 2009, 27:663-72.
11. Hoff AO, Toth BB, Altundag K. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. Journal of Bone and Mineral Research 2008, 23:826-36.
12. Hughes DE, Wright KR, Uy HL. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. Journal of Bone and Mineral Research 1995, 10:1478-87.
13. Kantarci A, Hasturk H, Van Dyke TE. Host-mediated resolution of inflammation in periodontal diseases. Periodontology 2000 2006, 40:144-63.
14. Khosla S, Burr D, Cauley J. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research 2007, 22:1479-91.
15. Lin SK, Hong CY, Chang HH. Immunolocalization of macrophages and transforming growth factor-β1 in induced rat periapical lesions. Journal of Endodontics 2000, 26:335-40.
16. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of Oral and Maxillofacial Surgery 2005, 63:1567-75.
17. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. Journal of Oral and Maxillofacial Surgery 2007, 65:415-23.
18. Palomo L, Liu J, Bissada NF. Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy. Expert Opinion on Pharmacotherapy 2007, 8:309-15.
19. Quinn R. Comparing rat's to human's age: how old is my rat in people years? Nutrition 2005, 21:775-7.
20. Roelofs AJ, Thompson K, Gordon S, Rogers MJ. Molecular mechanisms of action of bisphosphonates: current status. Clinical Cancer Research 2006, 12:6222s-30s.
21. Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. Journal of Dental Research 2007, 86:1013-21.
22. Santini D, Vespasiani Gentilucci U, Vincenzi B. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Annals of Oncology 2003, 14:1468-76.
23. Sarin J, DeRossi SS, Akintoye SO. Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Diseases 2008, 14:277-85.
24. Skoglund B, Holmertz J, Aspenberg P. Systemic and local ibandronate enhance screw fixation. Journal of Orthopaedic Research 2004, 22:1108-13.
25. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncology 2009, 45:164-72.
26. Spolidorio LC, Marcantonio E, Spolidorio DM. Alendronate therapy in cyclosporine-induced alveolar bone loss in rats. Journal of Periodontal Research 2007, 42:466-73.
27. Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation. Critical Reviews in Oral Biology & Medicine 1998, 9:498-521.
28. Tenenbaum HC, Shelemay A, Girard B, Zohar R, Fritz PC. Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses. Journal of Periodontology 2002, 73:813-22.
29. Tjäderhane L, Hotakainen T, Kinnunen S, Ahonen M, Salo T. The effect of chemical inhibition of matrix metalloproteinases on the size of experimentally induced apical periodontitis. International Endodontic Journal 2007, 40:282-9.
30. Walter C, Grötz KA, Kunkel M, Al-Nawas B. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Supportive Care in Cancer 2007, 15:197-202.
31. Wang L, Peng B. Correlation between platelet-derived growth factor B chain and bone resorption in rat periapical lesions. Journal of Endodontics 2007, 33:709-11.
32. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. Journal of Oral and Maxillofacial Surgery 2003, 61:1104-7.
33. Xiong H, Peng B, Wei L, Zhang X, Wang L. Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Journal of Endodontics 2007, 33:1304-8.
34. Xiong H, Wei L, Peng B. Immunohistochemical localization of IL-17 in induced rat periapical lesions. Journal of Endodontics 2009, 35:216-20.
35. Zhang X, Peng B. Immunolocalization of receptor activator of NF kappa B ligand in rat periapical lesions. Journal of Endodontics 2005, 31:574-7.